From May 28 to June 8, 2018, the company launched a new round of clinical application and verification evalsuation of non-invasive blood pressure measurement in Xingtai City, Hebei Province. The evalsuation work was supported by the Institute of Life Information Monitoring Technology and Application of Shenzhen University. People who participating in this evalsuation include a clinician from the company, two clinical nurses, and three graduate students from Shenzhen University.
The company's non-invasive blood pressure measurement PhD research team has been committed to the research of non-invasive blood pressure measurement, and has achieved breakthrough results in blood pressure measurement range, blood pressure measurement time, blood pressure measurement accuracy, etc., respectively, in boost blood pressure measurement and step deflation blood pressure measurement. And has successfully achieved product conversion, and passed the validation and reliability verification of the laboratory. Therefore, this non-invasive blood pressure clinical application and evalsuation work is mainly carried out for the blood pressure measurement research team's technical improvement in blood pressure measurement, so as to verify the effectiveness and reliability of its clinical application, obtain clinical data, and further promote the company's construction of blood pressure database. In this evalsuation, the company used a non-invasive blood pressure measurement data collection and verification platform based on standard requirements, and compared it with double-blind auscultation. The evalsuation will last for 2 weeks and it is expected that nearly 600 clinical data will be collected.
Since its establishment, the company has made breakthroughs in the field of non-invasive life information parameters, ECG monitoring and diagnosis, arteriosesclerosis detection, non-invasive cardiac output detection, and electronic auscultation. Therefore, during the evalsuation period, the joint evalsuation of non-invasive hemodynamic status based on pulse wave and extremity blood pressure, non-invasive cardiac output monitoring and evalsuation based on cardiac impedance, evalsuation of ECG monitoring and diagnostic algorithms, and evalsuation of the effectiveness of electronic auscultation are also carried out. The joint evalsuations above will Collect 200 clinical data to verify the validity and reliability of each parameter application.
